Literature DB >> 16061467

Model policy for the use of controlled substances for the treatment of pain.

.   

Abstract

The Federation of State Medical Boards of the United States published Model Guideline for the Use of Controlled Substances in the Management of Pain in 1998 and expanded it to this Model Policy in October 2004. The Model Policy is designed to communicate to licensees that the state medical board views pain management to be important and integral to the practice of medicine; that opioid analgesics may be necessary for the relief of pain; that the use of opioids for other than legitimate medical purposes poses a threat to the individual and society; that physicians have a responsibility to minimize the potential for the abuse and diversion of controlled substances; and that physicians will not be sanctioned solely for prescribing opioid analgesics for legitimate medical purposes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061467

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  25 in total

1.  Representations of OxyContin in North American newspapers and medical journals.

Authors:  Emma Whelan; Mark Asbridge; Susan Haydt
Journal:  Pain Res Manag       Date:  2011 Jul-Aug       Impact factor: 3.037

Review 2.  Issues in long-term opioid therapy: unmet needs, risks, and solutions.

Authors:  Steven D Passik
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

Review 3.  Informed consent in opioid therapy: a potential obligation and opportunity.

Authors:  Martin D Cheatle; Seddon R Savage
Journal:  J Pain Symptom Manage       Date:  2012-03-21       Impact factor: 3.612

4.  Geographic variation in opioid prescribing in the U.S.

Authors:  Douglas C McDonald; Kenneth Carlson; David Izrael
Journal:  J Pain       Date:  2012-10       Impact factor: 5.820

5.  Survey of Primary-Care Providers on Perceived Benefits of and Barriers to PainTracker.

Authors:  Melissa M Schorn; Ardith Z Doorenbos; Debra Gordon; Patricia Read-Williams
Journal:  J Nurse Pract       Date:  2014-12       Impact factor: 0.767

6.  A Comparison of Daily Average Consumption Of Oxycodone Controlled Release (OxyContin CR) And Oxymorphone Extended Release (Opana ER) In Patients With Low Back Pain.

Authors:  Todd Berner; Heather Thomson; Ann Hartry; R Amy Puenpatom; Rami Ben-Joseph; Sheryl L Szeinbach
Journal:  P T       Date:  2011-03

7.  Family reports of pain in dying hospitalized patients: a structured telephone survey.

Authors:  S W Tolle; V P Tilden; S E Hickman; A G Rosenfeld
Journal:  West J Med       Date:  2000-06

8.  The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription.

Authors:  Mark J Edlund; Bradley C Martin; Joan E Russo; Andrea DeVries; Jennifer B Braden; Mark D Sullivan
Journal:  Clin J Pain       Date:  2014-07       Impact factor: 3.442

9.  Promoting a "good death": determinants of pain-management policies in the United States.

Authors:  Sara L Imhof; Brian Kaskie
Journal:  J Health Polit Policy Law       Date:  2008-10       Impact factor: 2.265

10.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.